CVS HEALTH Corp
CVSFigures shown here come from public SEC filings. Dates beside each section show the available history.
How CVS HEALTH Corp Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 19 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
No 13F rows are listed for CVS HEALTH Corp.
- 8 rows left out: they repeat the same share count and value quarter after quarter, which a market value cannot do.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among CVS HEALTH Corp's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-05-19 · ROBBINS LARRY: Larger than all 18 other insider sales of Common Stock on file. SEC filing
- 2025-05-02 · ROBBINS LARRY: Larger than 17 of the 18 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-21 | ROBBINS LARRY · Director | Cash-Settled Swaps | S — Open market or private sale | −378,000 | 93.31 | SEC filing |
| 2026-05-21 | ROBBINS LARRY · Director | Common Stock | S — Open market or private sale | −370,462 | 93.45 | SEC filing |
| 2026-05-20 | ROBBINS LARRY · Director | Common Stock | S — Open market or private sale | −66,881 | 95.67 | SEC filing |
| 2026-05-20 | ROBBINS LARRY · Director | Common Stock | S — Open market or private sale | −152,691 | 94.81 | SEC filing |
| 2026-05-20 | ROBBINS LARRY · Director | Common Stock | S — Open market or private sale | −797,628 | 93.48 | SEC filing |
| 2026-05-20 | ROBBINS LARRY · Director | Common Stock | S — Open market or private sale | −800 | 96.28 | SEC filing |
| 2026-05-19 | ROBBINS LARRY · Director | Common Stock | S — Open market or private sale | −1,983,387 | 94.45 | SEC filing |
| 2026-05-19 | ROBBINS LARRY · Director | Common Stock | S — Open market or private sale | −151 | 95.18 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-26 | Clark James David · SVP, Cont & Chief Acct Officer | Common Stock (Restricted) | F — Payment of exercise price or tax by delivering securities | −454 | SEC filing |
| 2026-05-31 | Compton-Phillips Amy · EVP, Chief Medical Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −7,618 | SEC filing |
| 2026-05-31 | Newman Brian · EVP, Chief Financial Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −2,478 | SEC filing |
| 2026-05-14 | ROBBINS LARRY · Director | Deferred Stock Units | A — Grant, award, or other acquisition | +1,930 | SEC filing |
| 2026-05-14 | AGUIRRE FERNANDO · Director | Common Stock | A — Grant, award, or other acquisition | +1,563 | SEC filing |
| 2026-05-14 | Norwalk Leslie V · Director | Common Stock | A — Grant, award, or other acquisition | +1,447 | SEC filing |
| 2026-05-14 | KIRBY J SCOTT · Director | Common Stock | A — Grant, award, or other acquisition | +1,447 | SEC filing |
| 2026-05-14 | SANSONE GUY P · Director | Common Stock | A — Grant, award, or other acquisition | +1,447 | SEC filing |
Showing 8 of 27 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-21 | AGUIRRE FERNANDO · Director | Common Stock | D — Disposition to the issuer | −1,563 | SEC filing |
| 2026-05-20 | AGUIRRE FERNANDO · Director | Common Stock | D — Disposition to the issuer | −30,437 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.